Users' and carers' views of stratified medicine: phase 2
Research type
Research Study
Full title
Mental Health Service Users' and Carers' Views of Stratified Medicine for Treatment Resistant Schizophrenia: Phase 2
IRAS ID
178692
Contact name
Diana Rose
Contact email
Sponsor organisation
King's College London
Duration of Study in the UK
0 years, 7 months, 31 days
Research summary
The aim of this study is to find out the views of people with a diagnosis of psychosis and their carers on the possibility of antipsychotic medication being tailored to their biological makeup. This is known as stratified medicine. A researcher on the main clinical trial defines stratified medicine as 'the subdivision of individuals with the same diagnosis into two or more subgroups, who are predicted to respond to different treatments'. Six focus groups with service users and one with carers will be conducted. The academic researchers are also mental health service users with experience of taking psychiatric medication; this shared background can promote open and honest discussion with participants. The focus groups will be digitally recorded and transcribed and analysed for recurring themes. These results will ultimately be delivered to researchers conducting the main study, so that they can consider the views of people similar to those who will be participating in the eventual clinical trial.
REC name
London - Queen Square Research Ethics Committee
REC reference
15/LO/0867
Date of REC Opinion
9 Jun 2015
REC opinion
Further Information Favourable Opinion